AI Visibility Scorecard
Deep knowledge on small-molecule drugs and the global patents covering them
fdaorangebook.com · Finance & Insurance
Borderline visible. AI bots can crawl Deep knowledge on small-molecule drugs and the global patents covering them, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 4 times
Claude · Meta AI
#654,352 of 792,096 in Finance & Insurance for AI visibility
<1
4
AEO Visibility
iNear-invisible · 3.5/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
About Deep knowledge on small-molecule drugs and the global patents covering them
from our crawl and measurement
Deep knowledge on small-molecule drugs and the global patents covering them describes itself simply: "Get downloadable PDFs of the FDA Orange Book. Annual editions and monthly supplements from 1980 through August 2026." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 3.5 out of 10.
Our crawl found a readable heading structure. It is missing structured data describing the business, an llms.txt file and a sitemap.
AI crawlers have visited 2 times in our tracking, including ClaudeBot (Anthropic) and Meta AI.
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Fair
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 3.5/10, Deep knowledge on small-molecule drugs and the global patents covering them is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for Deep knowledge on small-molecule drugs and the global patents covering them
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Deep knowledge on small-molecule drugs and the global patents covering them.
Source & Attribution
Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/fdaorangebook
Cite this score: Engagemii (2026). "AEO Score for Deep knowledge on small-molecule drugs and the global patents covering them." Retrieved from https://engagemii.com/aeo/brands/fdaorangebook
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform